Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism METTL3 inhibitors(methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization 858 Therapeutics, Inc.Startup |
Active Organization 858 Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | US | 858 Therapeutics, Inc.Startup | 29 May 2024 |